Overexpression of ERBB4 was found to be closely related to poor outcomes and advanced tumor states (Muraoka-Cook et al., 2008) and inhibiting the expression of ERBB4 via the PI3K/Akt signaling pathway reduced the proliferation of gastric cancer cells (Xu et al., 2018). The gene discussed is AKT1; the disease is neoplasm.